Assignee
METAPROTEOMICS LLC
US·26 granted patents·21 pending applications·417 citations·filing 2001–2013
Top patents by PatentIndex Score
47 records- 0197US7431948B2Compositions that treat or inhibit pathological conditions associated with inflammatory responseMETAPROTEOMICS LLC·Filed 2006·Granted Oct 7, 2008·46 cites·23 claims
- 0296US7195785B2Complex mixtures exhibiting selective inhibition of cyclooxygenase-2METAPROTEOMICS LLC·Filed 2002·Granted Mar 27, 2007·66 cites·11 claims
- 0395US7270835B2Compositions that treat or inhibit pathological conditions associated with inflammatory responseMETAPROTEOMICS LLC·Filed 2003·Granted Sep 18, 2007·61 cites·8 claims
- 0493US7790205B2Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory responseMETAPROTEOMICS LLC·Filed 2006·Granted Sep 7, 2010·23 cites·18 claims
- 0592US7736677B2Xanthohumol and tetrahydro-isoalpha acid based protein kinase modulation cancer treatmentMETAPROTEOMICS LLC·Filed 2007·Granted Jun 15, 2010·11 cites·3 claims
- 0692US7332185B2Complex mixtures exhibiting selective inhibition of cyclooxygenase-2METAPROTEOMICS LLC·Filed 2002·Granted Feb 19, 2008·57 cites·10 claims
- 0792US7205151B2Complex mixtures exhibiting selective inhibition of cyclooxygenase-2METAPROTEOMICS LLC·Filed 2001·Granted Apr 17, 2007·60 cites·7 claims
- 0890US7722903B2Modulation of inflammation by hops fractions and derivativesMETAPROTEOMICS LLC·Filed 2006·Granted May 25, 2010·5 cites·4 claims
- 0988US7820206B2Modulation of inflammation by hops fractions and derivativesMETAPROTEOMICS LLC·Filed 2006·Granted Oct 26, 2010·3 cites·8 claims
- 1088US7666449B2Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicityMETAPROTEOMICS LLC·Filed 2006·Granted Feb 23, 2010·4 cites·8 claims
- 1187US7815944B2Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment of prevention of gastric toxicityMETAPROTEOMICS LLC·Filed 2006·Granted Oct 19, 2010·3 cites·12 claims
- 1287US7807203B2Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicityMETAPROTEOMICS LLC·Filed 2009·Granted Oct 5, 2010·3 cites·5 claims
- 1384US7682636B2Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2METAPROTEOMICS LLC·Filed 2007·Granted Mar 23, 2010·5 cites·6 claims
- 1484US6733793B2Oral composition with insulin-like activities and methods of useMETAPROTEOMICS LLC·Filed 2002·Granted May 11, 2004·14 cites·22 claims
- 1582US7794757B2Modulation of inflammation by hops fractions and derivativesMETAPROTEOMICS LLC·Filed 2006·Granted Sep 14, 2010·3 cites·4 claims
- 1682US7718198B2Treatment modalities for autoimmune diseasesMETAPROTEOMICS LLC·Filed 2006·Granted May 18, 2010·6 cites·8 claims
- 1782US6979470B2Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2METAPROTEOMICS LLC·Filed 2002·Granted Dec 27, 2005·14 cites·16 claims
- 1880US7919125B2Modulation of inflammation by hops fractions and derivativesMETAPROTEOMICS LLC·Filed 2010·Granted Apr 5, 2011·3 cites·4 claims
- 1980US6908630B2Combinations of sesquiterpene lactones and ditepene triepoxide lactones for synergistic inhibition of cyclooxygenase-2METAPROTEOMICS LLC·Filed 2001·Granted Jun 21, 2005·10 cites·25 claims
- 2079US6629835B2Combinations of diterpene triepoxide lactones and ditepene lactones or triterpenes for synergistic inhibition of cyclooxygenase-2METAPROTEOMICS LLC·Filed 2001·Granted Oct 7, 2003·8 cites·6 claims
- 2173US8846115B2Anti-inflammatory cyclooxygenase inhibitorsMETAPROTEOMICS LLC·Filed 2013·Granted Sep 30, 2014·1 cites·1 claims
- 2272US6506420B2Combinations of psyllium and chitosan for synergistic adsorption of triglycerideMETAPROTEOMICS LLC·Filed 2002·Granted Jan 14, 2003·2 cites·10 claims
- 2370US7901713B2Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hopsMETAPROTEOMICS LLC·Filed 2004·Granted Mar 8, 2011·4 cites·15 claims
- 2470US7811610B2Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicityMETAPROTEOMICS LLC·Filed 2004·Granted Oct 12, 2010·4 cites·7 claims
- 2565US7914831B2Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthinesMETAPROTEOMICS LLC·Filed 2004·Granted Mar 29, 2011·1 cites·13 claims
- 2664US2010112099A1Phytochemical compositions and methods for activating amp-kinaseMETAPROTEOMICS LLC·Filed 2009·Application pending·0 cites
- 2763US2008026088A1Reduced isoalpha acid based protein kinase modulation cancer treatmentMETAPROTEOMICS LLC·Filed 2007·Application pending·0 cites
- 2863US2008033057A1Hexahydro-isoalpha acid based protein kinase modulation cancer treatmentMETAPROTEOMICS LLC·Filed 2007·Application pending·0 cites
- 2963US2008031893A1Acacia based protein kinase modulation cancer treatmentMETAPROTEOMICS LLC·Filed 2007·Application pending·0 cites
- 3063US2008031982A1Tetrahydro-isoalpha acid based protein kinase modulation cancer treatmentMETAPROTEOMICS LLC·Filed 2007·Application pending·0 cites
- 3163US2008031894A1Beta acid based protein kinase modulation cancer treatmentMETAPROTEOMICS LLC·Filed 2007·Application pending·0 cites
- 3263US2008033056A1Xanthohumol based protein kinase modulation cancer treatmentMETAPROTEOMICS LLC·Filed 2007·Application pending·0 cites
- 3360US2010069422A1Methods and compositions for promoting bone and joint healthMETAPROTEOMICS LLC·Filed 2009·Application pending·0 cites
- 3458US2007172532A1Complex Mixtures Exhibiting Selective Inhibition of Cyclooxygenase-2METAPROTEOMICS LLC·Filed 2007·Application pending·0 cites
- 3557US2008051466A1Isoalpha acid based protein kinase modulation cancer treatmentMETAPROTEOMICS LLC·Filed 2007·Application pending·0 cites
- 3657US2011275721A1Method for the purification of substituted cyclopent-2-en-1-one congeners and substituted 1,3-cyclopentadione congeners from a complex mixture using countercurrent separationMETAPROTEOMICS LLC·Filed 2009·Application pending·0 cites
- 3757US2011257074A1Method for the purification of substituted cyclopent-2-en-1-one congeners and substituted 1,3-cyclopentadione congeners from a complex mixture using countercurrent separationMETAPROTEOMICS LLC·Filed 2009·Application pending·0 cites
- 3854US2008031986A1Protein kinase modulation by hops and acacia productsMETAPROTEOMICS LLC·Filed 2007·Application pending·0 cites
- 3953US2010215782A1Novel mitochondrial uncoupling methods and compositions for enhancing adipocyte thermogenesisMETAPROTEOMICS LLC·Filed 2009·Application pending·0 cites
- 4051US2011021637A1Xanthohumol and tetrahydro-isoalpha acid based protein kinase modulation cancer treatmentMETAPROTEOMICS LLC·Filed 2010·Application pending·0 cites
- 4150US2014335061A1Supplemented oil compositions and methods for improved healthMETAPROTEOMICS LLC·Filed 2012·Application pending·0 cites
- 4249US2010222262A1Substituted 1, 3-cyclopentadione attenuated endothelial inflammation and endothelial-monocyte interactionsMETAPROTEOMICS LLC·Filed 2009·Application pending·0 cites
- 4349US2010137449A1Substituted 1,3-cyclopentadione multi-target protein kinase modulators of cancer, angiogenesis and the inflammatory pathways associated therewithMETAPROTEOMICS LLC·Filed 2008·Application pending·0 cites
- 4446US2013337092A1Phytonutrient compositions and methods of useMETAPROTEOMICS LLC·Filed 2013·Application pending·0 cites
- 4544US10220068B2Phytonutrient compositions and methods to protect against radical mediated cellular and DNA damageMETAPROTEOMICS LLC·Filed 2012·Granted Mar 5, 2019·0 cites·18 claims
- 4637US2011135768A1Dihydro-isoalpha acid and acacia nilotica extract based compositions and methods for weight managementMETAPROTEOMICS LLC·Filed 2010·Application pending·0 cites
- 4737US2011136917A1Tetrahydro-isoalpha acid compositions and methods for weight managementMETAPROTEOMICS LLC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when METAPROTEOMICS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →